Posted on 09/23/2020 7:43:54 PM PDT by SeekAndFind
A university hospital in Tokyo says it will soon begin a clinical trial of an anti-parasite drug as a possible treatment for COVID-19.
Kitasato University Hospital on Thursday announced plans for testing Ivermectin, which is widely used against parasite-borne infectious diseases.
The university's Distinguished Emeritus Professor, Omura Satoshi, won a Nobel prize for discovering a compound that led to the development of Ivermectin.
The university hospital says the trial will involve 240 COVID-19 patients aged 20 or over with mild to moderate symptoms.
They will be divided into two groups. One will be given Ivermectin, and the other will receive a placebo.
The hospital plans to compare changes in their symptoms to assess the drug's efficacy and safety. The trial will continue through the end of March.
The operator of the university, the Kitasato Institute, says experiments using cells have shown Ivermectin works in inhibiting the proliferation of the coronavirus.
It says it will strictly examine the safety and efficacy of Ivermectin to obtain approval for the drug as a treatment for COVID-19.
Ping.
How many months ago did we here ivermectin helped cure the Wuhan here on FR?
RE: How many months ago did we here ivermectin helped cure the Wuhan here on FR?
_________________________________
From my search of the keyword ‘Ivermectin’ in FR, the news about this treatment was posted here as early as April 2020.
See here for the search results:
And its apple flavored.
That is unethical I would think.
If they get grape, I’m in.
Not purple grape, green grape...
How much ivermectin how often?
Thank you.
It is an interesting possibility.
Colloidal silver kills all viruses and it’s free
Please send me all your free silver, thanks
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.